What is a stock summary page? Click here for an overview.
Business Description
Kukje Pharma Co Ltd
ISIN : KR7002720001
Compare
Compare
Traded in other countries / regions
002720.Korea Index Membership
KOSPI IPO Date
1975-12-27Description
Kukje Pharma Co Ltd engages in manufacturing, importing, exporting, selling, and distributing pharmaceutical products internationally. The company offers pharmaceutical products, including ETC and OTC products, raw materials, intermediates, and side chain products, as well as cosmetics and health care products. Its products include cephalosporins, penicillins, quinolones, aminoglycosides, macrolides, antifungal and antiviral agents, and other antibiotics.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.3 | |||||
| Equity-to-Asset | 0.54 | |||||
| Debt-to-Equity | 0.33 | |||||
| Debt-to-EBITDA | 2.68 | |||||
| Interest Coverage | 5.56 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 2.11 | |||||
| Beneish M-Score | -2.28 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 10.9 | |||||
| 3-Year EBITDA Growth Rate | 42.1 | |||||
| 3-Year FCF Growth Rate | -49.4 | |||||
| 3-Year Book Growth Rate | 9.1 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 58.92 | |||||
| 9-Day RSI | 57.42 | |||||
| 14-Day RSI | 53.67 | |||||
| 3-1 Month Momentum % | -7.19 | |||||
| 6-1 Month Momentum % | -10.4 | |||||
| 12-1 Month Momentum % | -6.91 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2 | |||||
| Quick Ratio | 1.21 | |||||
| Cash Ratio | 0.31 | |||||
| Days Inventory | 107.4 | |||||
| Days Sales Outstanding | 48.02 | |||||
| Days Payable | 46.46 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.64 | |||||
| Forward Dividend Yield % | 0.64 | |||||
| 5-Year Yield-on-Cost % | 0.64 | |||||
| 3-Year Average Share Buyback Ratio | -0.2 | |||||
| Shareholder Yield % | 1.88 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 52.73 | |||||
| Operating Margin % | 4.28 | |||||
| Net Margin % | 3.33 | |||||
| FCF Margin % | 0.6 | |||||
| ROE % | 5.9 | |||||
| ROA % | 3.19 | |||||
| ROIC % | 3.79 | |||||
| 3-Year ROIIC % | 821.85 | |||||
| ROC (Joel Greenblatt) % | 6.67 | |||||
| ROCE % | 6.53 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 18.44 | |||||
| PE Ratio without NRI | 18.16 | |||||
| PS Ratio | 0.61 | |||||
| PB Ratio | 1.07 | |||||
| Price-to-Tangible-Book | 1.08 | |||||
| Price-to-Free-Cash-Flow | 96.51 | |||||
| Price-to-Operating-Cash-Flow | 24.1 | |||||
| EV-to-EBIT | 14.95 | |||||
| EV-to-EBITDA | 10.61 | |||||
| EV-to-Revenue | 0.75 | |||||
| EV-to-FCF | 123.65 | |||||
| Price-to-GF-Value | 0.79 | |||||
| Price-to-Projected-FCF | 1.19 | |||||
| Price-to-Median-PS-Value | 0.83 | |||||
| Price-to-Graham-Number | 0.94 | |||||
| Earnings Yield (Greenblatt) % | 6.69 | |||||
| FCF Yield % | 0.98 | |||||
| Forward Rate of Return (Yacktman) % | 1.67 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Kukje Pharma Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 156,462.823 | ||
| EPS (TTM) (â‚©) | 256 | ||
| Beta | 0.49 | ||
| 3-Year Sharpe Ratio | -0.03 | ||
| 3-Year Sortino Ratio | -0.05 | ||
| Volatility % | 33.26 | ||
| 14-Day RSI | 53.67 | ||
| 14-Day ATR (â‚©) | 117.410448 | ||
| 20-Day SMA (â‚©) | 4601.25 | ||
| 12-1 Month Momentum % | -6.91 | ||
| 52-Week Range (â‚©) | 4285 - 7840 | ||
| Shares Outstanding (Mil) | 20.36 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Kukje Pharma Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Kukje Pharma Co Ltd Stock Events
| Event | Date | Price (â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Kukje Pharma Co Ltd Frequently Asked Questions
What is Kukje Pharma Co Ltd(XKRX:002720)'s stock price today?
The current price of XKRX:002720 is â‚©4720.00. The 52 week high of XKRX:002720 is â‚©7840.00 and 52 week low is â‚©4285.00.
When is next earnings date of Kukje Pharma Co Ltd(XKRX:002720)?
The next earnings date of Kukje Pharma Co Ltd(XKRX:002720) is .
Does Kukje Pharma Co Ltd(XKRX:002720) pay dividends? If so, how much?
The Dividend Yield %  of Kukje Pharma Co Ltd(XKRX:002720) is 0.64% (As of Today), Highest Dividend Payout Ratio of Kukje Pharma Co Ltd(XKRX:002720) was 0.19. The lowest was 0.17. And the median was 0.19. The  Forward Dividend Yield % of Kukje Pharma Co Ltd(XKRX:002720) is 0.64%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers